UTI Multi Cap Fund
Institution · data to Jun 2026
Disclosed value
₹14,254 Cr
Jun 2026 closes
At current prices
…
Current holdings
5
Tracked since
Jun 2017
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Bharti Airtel Ltd | 1.06% | 0.02 | ₹12,624 Cr |
| Glenmark Pharmaceuticals Ltd | 1.15% | NEW | ₹721 Cr |
| Affle 3i Ltd | 2.13% | 0.15 | ₹439 Cr |
| Caplin Point Laboratories Ltd | 1.81% | 0.04 | ₹350 Cr |
| PVR Inox Ltd | 1.23% | NEW | ₹120 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, UTI Multi Cap Fund — an institution tracked through public shareholding filings — disclosed 5 holdings in Indian listed companies worth ₹14,254 crore. The same holdings-at-filing-value basis put it at ₹16,817 crore in Mar 2026 (−15.2%). Solomo carries these filings back to Jun 2017.
Largest disclosed positions in Jun 2026: Bharti Airtel Ltd (BHARTIARTL — 1.06% of the company, ₹12,624 crore); Glenmark Pharmaceuticals Ltd (GLENMARK — 1.15% of the company, ₹721 crore); Affle 3i Ltd (AFFLE — 2.13% of the company, ₹439 crore); Caplin Point Laboratories Ltd (CAPLIPOINT — 1.81% of the company, ₹350 crore); PVR Inox Ltd (PVRINOX — 1.23% of the company, ₹120 crore).
Changes in the Jun 2026 filings: newly disclosed — Glenmark Pharmaceuticals Ltd, PVR Inox Ltd. Stake raised in Affle 3i Ltd (+0.15 pp), Bharti Airtel Ltd (+0.02 pp). Stake reduced in Caplin Point Laboratories Ltd (−0.04 pp). No longer disclosed after the previous quarter: Maruti Suzuki India Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹14,254 Cr | −15.2% |
| Mar 2026 | ₹16,817 Cr | +86.8% |
| Dec 2025 | ₹9,001 Cr | +3689.3% |
| Sep 2025 | ₹238 Cr | −63.2% |
| Jun 2025 | ₹645 Cr | - |
| Mar 2018 | ₹60 Cr | −12% |
| Dec 2017 | ₹68 Cr | +42.5% |
| Sep 2017 | ₹48 Cr | +5% |